iifl-logo-icon 1
iifl-logo-icon 1
iifl-logo-icon 1
Home

Sun Pharmaceuticals Industries Ltd AGM

₹1,533.95
(0.65%)
Jul 3, 2024|12:00:00 AM

Sun Pharma.Inds. CORPORATE ACTIONS

05/07/2023calendar-icon
04/07/2024calendar-icon
PurposeAGM DateAnnouncement Date
AGM28 Aug 20237 Jul 2023
This is to inform you that the 31st AGM of the members of Sun Pharmaceutical Industries Limited will be held on Monday, August 28, 2023 at 3.00 p.m. IST through Video Conferencing/ Other Audio-Visual Means. The Annual Report and the Notice of the AGM for FY2022-23, will be submitted to the stock exchanges and will be sent to the shareholders of the Company in due course. Pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Annual Report for the financial year 2022-23 including the Notice of Thirty-first Annual General Meeting (31st AGM) of the Company. The 31st AGM of the members of Sun Pharmaceutical Industries Limited will be held on Monday, August 28, 2023 at 3:00 p.m. IST through Video Conferencing/ Other Audio-Visual Means. The Cut-off date for the purpose of determining the Members eligible to vote on the resolutions set out in the Notice of 31st AGM is Monday, August 21, 2023. The Remote e-voting period begins on Thursday, August 24, 2023 at 09:00 a.m. IST and ends on Sunday, August 27, 2023 at 05:00 p.m. IST. (As Per BSE Announcement dated on 27.07.2023) Please find enclosed herewith the speech delivered at the 31st Annual General Meeting held on August 28, 2023. Proceedings of 31st AGM of the Company is attached. (As per BSE Announcement Dated on 28/08/2023) Voting Results and Scrutinizers Consolidated Report of the 31st Annual General Meeting of the Company held on August 28, 2023 are attached. (As per BSE Announcement Dated on 29/08/2023)

Sun Pharma.Inds.: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

QUICKLINKS FOR Sun Pharmaceuticals Industries Ltd

Information
Share PriceFutures PriceOption Chain
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.